<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://www.jcp.sagepub.com/">
<title>J Clin Pharmacol: Most-Read Full-Text Articles</title>
<link>http://www.jcp.sagepub.com/</link>
<description>Most-read rankings are recalculated at the beginning of the month based on usage of full-text and PDF views for the previous month.</description>
<prism:coverDisplayDate>2009-11-03</prism:coverDisplayDate>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/48/4/475?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/49/5/506?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/48/6/662?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/49/9/1091?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/49/10/1196?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/43/7/768?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/49/5/513?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/49/11/1284?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/49/10/1157?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/49/10/1176?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/49/10/1142?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/47/12/1570?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/49/8/886?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/49/8/957?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/47/12/1580?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/48/7/849?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/49/9/1012?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/47/12/1476?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/47/12/1555?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/47/12/1466?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/47/12/1498?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/47/12/1540?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/49/11/1297?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/49/7/838?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/49/2/162?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/47/12/1532?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/0091270009339191v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/49/7/824?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/44/1/7?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/47/3/383?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/49/9/1056?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/48/3/379?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/49/11/1309?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/47/5/553?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/0091270009347868v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/45/2/127?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/48/12/1389?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/45/8/872?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/49/7/758?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/47/12/1508?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/49/10/1228?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/0091270009337134v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/43/5/443?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/49/8/937?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/49/10/1210?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/43/3/211?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/46/1/10?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/47/5/566?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/49/8/984?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://www.jcp.sagepub.com/cgi/content/short/49/5/574?rss=1&amp;ssource=mfc" />
 </rdf:Seq>
</items>
</channel>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/48/4/475?rss=1&amp;ssource=mfc">
<title><![CDATA[Effects of the Proton Pump Inhibitor Lansoprazole on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/48/4/475?rss=1&amp;ssource=mfc</link>
<description><![CDATA[David S. Small, Nagy A. Farid, Christopher D. Payne, Govinda J. Weerakkody, Ying G. Li, John T. Brandt, Daniel E. Salazar, Kenneth J. Winters<br />Apr  1, 2008; 48:475-484<br />Drug Interactions]]></description>
<dc:creator>David S. Small, Nagy A. Farid, Christopher D. Payne, Govinda J. Weerakkody, Ying G. Li, John T. Brandt, Daniel E. Salazar, Kenneth J. Winters</dc:creator>
<dc:date>2008-04-01</dc:date>
<dc:title><![CDATA[Effects of the Proton Pump Inhibitor Lansoprazole on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/49/5/506?rss=1&amp;ssource=mfc">
<title><![CDATA[Clopidogrel Resistance: Pharmacokinetic or Pharmacogenetic?]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/49/5/506?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Neville F. Ford<br />May  1, 2009; 49:506-512<br />Commentary]]></description>
<dc:creator>Neville F. Ford</dc:creator>
<dc:date>2009-05-01</dc:date>
<dc:title><![CDATA[Clopidogrel Resistance: Pharmacokinetic or Pharmacogenetic?]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/48/6/662?rss=1&amp;ssource=mfc">
<title><![CDATA[New Era in Drug Interaction Evaluation: US Food and Drug Administration Update on CYP Enzymes, Transporters, and the Guidance Process]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/48/6/662?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Shiew-Mei Huang, John M. Strong, Lei Zhang, Kellie S. Reynolds, Srikanth Nallani, Robert Temple, Sophia Abraham, Sayed Al Habet, Raman K. Baweja, Gilbert J. Burckart, Sang Chung, Philip Colangelo, David Frucht, Martin D. Green, Paul Hepp, Elena Karnaukhova, Hon-Sum Ko, Jang-Ik Lee, Patrick J. Marroum, Janet M. Norden, Wei Qiu, Atiqur Rahman, Solomon Sobel, Toni Stifano, Kenneth Thummel, Xiao-xiong Wei, Sally Yasuda, Jenny H. Zheng, Hong Zhao, Lawrence J. Lesko<br />Jun  1, 2008; 48:662-670<br />Drug Interactions/Review]]></description>
<dc:creator>Shiew-Mei Huang, John M. Strong, Lei Zhang, Kellie S. Reynolds, Srikanth Nallani, Robert Temple, Sophia Abraham, Sayed Al Habet, Raman K. Baweja, Gilbert J. Burckart, Sang Chung, Philip Colangelo, David Frucht, Martin D. Green, Paul Hepp, Elena Karnaukhova, Hon-Sum Ko, Jang-Ik Lee, Patrick J. Marroum, Janet M. Norden, Wei Qiu, Atiqur Rahman, Solomon Sobel, Toni Stifano, Kenneth Thummel, Xiao-xiong Wei, Sally Yasuda, Jenny H. Zheng, Hong Zhao, Lawrence J. Lesko</dc:creator>
<dc:date>2008-06-01</dc:date>
<dc:title><![CDATA[New Era in Drug Interaction Evaluation: US Food and Drug Administration Update on CYP Enzymes, Transporters, and the Guidance Process]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/49/9/1091?rss=1&amp;ssource=mfc">
<title><![CDATA[Abstracts: Thirty-Eighth Annual Meeting American College of Clinical Pharmacology September 13-15, 2009 San Antonio, Texas]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/49/9/1091?rss=1&amp;ssource=mfc</link>
<description><![CDATA[<br />Sep  1, 2009; 49:1091-1130<br />ACCP Announcements]]></description>
<dc:date>2009-09-01</dc:date>
<dc:title><![CDATA[Abstracts: Thirty-Eighth Annual Meeting American College of Clinical Pharmacology September 13-15, 2009 San Antonio, Texas]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/49/10/1196?rss=1&amp;ssource=mfc">
<title><![CDATA[Bioavailability of Mycophenolate Mofetil and Enteric-Coated Mycophenolate Sodium Is Differentially Affected by Pantoprazole in Healthy Volunteers]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/49/10/1196?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Korbinian Rupprecht, Christoph Schmidt, Anne Raspe, Frank Schweda, Maria Shipkova, Wolfgang Fischer, Michael Bucher, Frieder Kees, Lothar Faerber<br />Oct  1, 2009; 49:1196-1201<br />Drug Interactions]]></description>
<dc:creator>Korbinian Rupprecht, Christoph Schmidt, Anne Raspe, Frank Schweda, Maria Shipkova, Wolfgang Fischer, Michael Bucher, Frieder Kees, Lothar Faerber</dc:creator>
<dc:date>2009-10-01</dc:date>
<dc:identifier>10.1177/0091270009344988</dc:identifier>
<dc:title><![CDATA[Bioavailability of Mycophenolate Mofetil and Enteric-Coated Mycophenolate Sodium Is Differentially Affected by Pantoprazole in Healthy Volunteers]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/43/7/768?rss=1&amp;ssource=mfc">
<title><![CDATA[Reducing Medication Errors and Increasing Patient Safety: Case Studies in Clinical Pharmacology]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/43/7/768?rss=1&amp;ssource=mfc</link>
<description><![CDATA[David M. Benjamin<br />Jul  1, 2003; 43:768-783<br />Symposium]]></description>
<dc:creator>David M. Benjamin</dc:creator>
<dc:date>2003-07-01</dc:date>
<dc:identifier>10.1177/0091270003254794</dc:identifier>
<dc:title><![CDATA[Reducing Medication Errors and Increasing Patient Safety: Case Studies in Clinical Pharmacology]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/49/5/513?rss=1&amp;ssource=mfc">
<title><![CDATA[Prediction of Human Pharmacokinetics From Preclinical Information: Comparative Accuracy of Quantitative Prediction Approaches]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/49/5/513?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Natilie A. Hosea, Wendy T. Collard, Susan Cole, Tristan S. Maurer, Rick X. Fang, Hannah Jones, Shefali M. Kakar, Yasuhiro Nakai, Bill J. Smith, Rob Webster, Kevin Beaumont<br />May  1, 2009; 49:513-533<br />Review]]></description>
<dc:creator>Natilie A. Hosea, Wendy T. Collard, Susan Cole, Tristan S. Maurer, Rick X. Fang, Hannah Jones, Shefali M. Kakar, Yasuhiro Nakai, Bill J. Smith, Rob Webster, Kevin Beaumont</dc:creator>
<dc:date>2009-05-01</dc:date>
<dc:title><![CDATA[Prediction of Human Pharmacokinetics From Preclinical Information: Comparative Accuracy of Quantitative Prediction Approaches]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/49/11/1284?rss=1&amp;ssource=mfc">
<title><![CDATA[Is a Thorough QTc Study Necessary? The Role of Modeling and Simulation in Evaluating the QTc Prolongation Potential of Drugs]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/49/11/1284?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Shashank Rohatagi, Timothy J. Carrothers, Jon Kuwabara-Wagg, Tatiana Khariton<br />Nov  1, 2009; 49:1284-1296<br />Pharmacokinetics and Pharmacodynamics]]></description>
<dc:creator>Shashank Rohatagi, Timothy J. Carrothers, Jon Kuwabara-Wagg, Tatiana Khariton</dc:creator>
<dc:date>2009-11-01</dc:date>
<dc:title><![CDATA[Is a Thorough QTc Study Necessary? The Role of Modeling and Simulation in Evaluating the QTc Prolongation Potential of Drugs]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/49/10/1157?rss=1&amp;ssource=mfc">
<title><![CDATA[Multiple Doses of Sitagliptin, a Selective DPP-4 Inhibitor, Do Not Meaningfully Alter Pharmacokinetics and Pharmacodynamics of Warfarin]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/49/10/1157?rss=1&amp;ssource=mfc</link>
<description><![CDATA[D. Hamish Wright, Gary A. Herman, Andrea Maes, Qi Liu, Amy O. Johnson-Levonas, John A. Wagner<br />Oct  1, 2009; 49:1157-1167<br />Pharmacokinetics and Pharmacodynamics]]></description>
<dc:creator>D. Hamish Wright, Gary A. Herman, Andrea Maes, Qi Liu, Amy O. Johnson-Levonas, John A. Wagner</dc:creator>
<dc:date>2009-10-01</dc:date>
<dc:identifier>10.1177/0091270009341653</dc:identifier>
<dc:title><![CDATA[Multiple Doses of Sitagliptin, a Selective DPP-4 Inhibitor, Do Not Meaningfully Alter Pharmacokinetics and Pharmacodynamics of Warfarin]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/49/10/1176?rss=1&amp;ssource=mfc">
<title><![CDATA[Anticholinergic Activity of Commonly Prescribed Medications and Neuropsychiatric Adverse Events in Older People]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/49/10/1176?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Prasad S. Nishtala, Romano A. Fois, Andrew J. McLachlan, J. Simon Bell, Patrick J. Kelly, Timothy F. Chen<br />Oct  1, 2009; 49:1176-1184<br />Pharmacodynamics]]></description>
<dc:creator>Prasad S. Nishtala, Romano A. Fois, Andrew J. McLachlan, J. Simon Bell, Patrick J. Kelly, Timothy F. Chen</dc:creator>
<dc:date>2009-10-01</dc:date>
<dc:identifier>10.1177/0091270009345690</dc:identifier>
<dc:title><![CDATA[Anticholinergic Activity of Commonly Prescribed Medications and Neuropsychiatric Adverse Events in Older People]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/49/10/1142?rss=1&amp;ssource=mfc">
<title><![CDATA[Population Pharmacokinetic Analysis of Panitumumab in Patients With Advanced Solid Tumors]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/49/10/1142?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Peiming Ma, Bing-Bing Yang, Yow-Ming Wang, Mark Peterson, Adimoolam Narayanan, Liviawati Sutjandra, Rachelle Rodriguez, Andrew Chow<br />Oct  1, 2009; 49:1142-1156<br />Special Populations]]></description>
<dc:creator>Peiming Ma, Bing-Bing Yang, Yow-Ming Wang, Mark Peterson, Adimoolam Narayanan, Liviawati Sutjandra, Rachelle Rodriguez, Andrew Chow</dc:creator>
<dc:date>2009-10-01</dc:date>
<dc:title><![CDATA[Population Pharmacokinetic Analysis of Panitumumab in Patients With Advanced Solid Tumors]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/47/12/1570?rss=1&amp;ssource=mfc">
<title><![CDATA[Antiretroviral Drugs]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/47/12/1570?rss=1&amp;ssource=mfc</link>
<description><![CDATA[David Warnke, Jason Barreto, Zelalem Temesgen<br />Dec  1, 2007; 47:1570-1579<br />Therapeutic Review]]></description>
<dc:creator>David Warnke, Jason Barreto, Zelalem Temesgen</dc:creator>
<dc:date>2007-12-01</dc:date>
<dc:identifier>10.1177/0091270007308034</dc:identifier>
<dc:title><![CDATA[Antiretroviral Drugs]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/49/8/886?rss=1&amp;ssource=mfc">
<title><![CDATA[Direct-to-Consumer/Patient Advertising of Genetic Testing: A Position Statement of the American College of Clinical Pharmacology]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/49/8/886?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Barbara Ameer, Norberto Krivoy<br />Aug  1, 2009; 49:886-888<br />ACCP Position Statement]]></description>
<dc:creator>Barbara Ameer, Norberto Krivoy</dc:creator>
<dc:date>2009-08-01</dc:date>
<dc:identifier>10.1177/0091270009335948</dc:identifier>
<dc:title><![CDATA[Direct-to-Consumer/Patient Advertising of Genetic Testing: A Position Statement of the American College of Clinical Pharmacology]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/49/8/957?rss=1&amp;ssource=mfc">
<title><![CDATA[Pharmacological Aspects and Potential New Clinical Applications of Ketamine: Reevaluation of an Old Drug]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/49/8/957?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Filippia Aroni, Nicoletta Iacovidou, Ismene Dontas, Chryssa Pourzitaki, Theodoros Xanthos<br />Aug  1, 2009; 49:957-964<br />Pharmacodynamics]]></description>
<dc:creator>Filippia Aroni, Nicoletta Iacovidou, Ismene Dontas, Chryssa Pourzitaki, Theodoros Xanthos</dc:creator>
<dc:date>2009-08-01</dc:date>
<dc:title><![CDATA[Pharmacological Aspects and Potential New Clinical Applications of Ketamine: Reevaluation of an Old Drug]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/47/12/1580?rss=1&amp;ssource=mfc">
<title><![CDATA[A Randomized Study of the Bioavailability of Different Formulations of Coenzyme Q10 (Ubiquinone)]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/47/12/1580?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Radu Constantinescu, Michael P. McDermott, Robert DiCenzo, Elisabeth A. de Blieck, H. Christopher Hyson, M. Flint Beal, Edward M. Bednarczyk, Mikhail Bogdanov, Linda J. Metakis, Susan E. Browne, Beverly J. Lorenzo, Bernard Ravina, Karl Kieburtz<br />Dec  1, 2007; 47:1580-1586<br />]]></description>
<dc:creator>Radu Constantinescu, Michael P. McDermott, Robert DiCenzo, Elisabeth A. de Blieck, H. Christopher Hyson, M. Flint Beal, Edward M. Bednarczyk, Mikhail Bogdanov, Linda J. Metakis, Susan E. Browne, Beverly J. Lorenzo, Bernard Ravina, Karl Kieburtz</dc:creator>
<dc:date>2007-12-01</dc:date>
<dc:title><![CDATA[A Randomized Study of the Bioavailability of Different Formulations of Coenzyme Q10 (Ubiquinone)]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/48/7/849?rss=1&amp;ssource=mfc">
<title><![CDATA[PhRMA White Paper on ADME Pharmacogenomics]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/48/7/849?rss=1&amp;ssource=mfc</link>
<description><![CDATA[J. Andrew Williams, Tommy Andersson, Tommy B. Andersson, Rebecca Blanchard, Martin Otto Behm, Nadine Cohen, Timi Edeki, Monique Franc, Kathleen M. Hillgren, Keith J. Johnson, David A. Katz, Mark N. Milton, Bernard P. Murray, Joseph W. Polli, Deb Ricci, Lisa A. Shipley, Subrahmanyam Vangala, Steven A. Wrighton<br />Jul  1, 2008; 48:849-889<br />Pharmacogenomics]]></description>
<dc:creator>J. Andrew Williams, Tommy Andersson, Tommy B. Andersson, Rebecca Blanchard, Martin Otto Behm, Nadine Cohen, Timi Edeki, Monique Franc, Kathleen M. Hillgren, Keith J. Johnson, David A. Katz, Mark N. Milton, Bernard P. Murray, Joseph W. Polli, Deb Ricci, Lisa A. Shipley, Subrahmanyam Vangala, Steven A. Wrighton</dc:creator>
<dc:date>2008-07-01</dc:date>
<dc:title><![CDATA[PhRMA White Paper on ADME Pharmacogenomics]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/49/9/1012?rss=1&amp;ssource=mfc">
<title><![CDATA[Fixed Dosing Versus Body Size-Based Dosing of Monoclonal Antibodies in Adult Clinical Trials]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/49/9/1012?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Diane D. Wang, Shuzhong Zhang, Hong Zhao, Angela Y. Men, Kourosh Parivar<br />Sep  1, 2009; 49:1012-1024<br />Pharmacokinetics and Pharmacodynamics]]></description>
<dc:creator>Diane D. Wang, Shuzhong Zhang, Hong Zhao, Angela Y. Men, Kourosh Parivar</dc:creator>
<dc:date>2009-09-01</dc:date>
<dc:title><![CDATA[Fixed Dosing Versus Body Size-Based Dosing of Monoclonal Antibodies in Adult Clinical Trials]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/47/12/1476?rss=1&amp;ssource=mfc">
<title><![CDATA[Assessment of Pharmacokinetics and Pharmacodynamic Effects Related to Abuse Potential of a Unique Oral Osmotic-Controlled Extended-Release Methylphenidate Formulation in Humans]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/47/12/1476?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Dolly A. Parasrampuria, Kerri A. Schoedel, Reinhard Schuller, Joan Gu, Patrick Ciccone, Steven A. Silber, Edward M. Sellers<br />Dec  1, 2007; 47:1476-1488<br />Pharmacokinetics and Pharmacodynamics]]></description>
<dc:creator>Dolly A. Parasrampuria, Kerri A. Schoedel, Reinhard Schuller, Joan Gu, Patrick Ciccone, Steven A. Silber, Edward M. Sellers</dc:creator>
<dc:date>2007-12-01</dc:date>
<dc:title><![CDATA[Assessment of Pharmacokinetics and Pharmacodynamic Effects Related to Abuse Potential of a Unique Oral Osmotic-Controlled Extended-Release Methylphenidate Formulation in Humans]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/47/12/1555?rss=1&amp;ssource=mfc">
<title><![CDATA[A Randomized, Placebo-Controlled Trial to Evaluate the Efficacy, Safety, and Pharmacodynamic Interaction of Coadministered Amlodipine and Atorvastatin in 1660 Patients With Concomitant Hypertension and Dyslipidemia: The Respond Trial]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/47/12/1555?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Richard A. Preston, Peter Harvey, Ottmar Herfert, Gary Dykstra, J. Wouter Jukema, Franklin Sun, David Gillen<br />Dec  1, 2007; 47:1555-1569<br />]]></description>
<dc:creator>Richard A. Preston, Peter Harvey, Ottmar Herfert, Gary Dykstra, J. Wouter Jukema, Franklin Sun, David Gillen</dc:creator>
<dc:date>2007-12-01</dc:date>
<dc:identifier>10.1177/0091270007307879</dc:identifier>
<dc:title><![CDATA[A Randomized, Placebo-Controlled Trial to Evaluate the Efficacy, Safety, and Pharmacodynamic Interaction of Coadministered Amlodipine and Atorvastatin in 1660 Patients With Concomitant Hypertension and Dyslipidemia: The Respond Trial]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/47/12/1466?rss=1&amp;ssource=mfc">
<title><![CDATA[Pharmacokinetics of Lenalidomide in Subjects With Various Degrees of Renal Impairment and in Subjects on Hemodialysis]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/47/12/1466?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Nianhang Chen, Henry Lau, Linghui Kong, Gondi Kumar, Jerome B. Zeldis, Robert Knight, Oscar L. Laskin<br />Dec  1, 2007; 47:1466-1475<br />Pharmacokinetics/Special Populations]]></description>
<dc:creator>Nianhang Chen, Henry Lau, Linghui Kong, Gondi Kumar, Jerome B. Zeldis, Robert Knight, Oscar L. Laskin</dc:creator>
<dc:date>2007-12-01</dc:date>
<dc:title><![CDATA[Pharmacokinetics of Lenalidomide in Subjects With Various Degrees of Renal Impairment and in Subjects on Hemodialysis]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/47/12/1498?rss=1&amp;ssource=mfc">
<title><![CDATA[Pharmacokinetics, Pharmacodynamics, and Safety of Tolvaptan, a Nonpeptide AVP Antagonist, During Ascending Single-Dose Studies in Healthy Subjects]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/47/12/1498?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Susan E. Shoaf, Zhao Wang, Patricia Bricmont, Suresh Mallikaarjun<br />Dec  1, 2007; 47:1498-1507<br />Pharmacokinetics and Pharmacodynamics]]></description>
<dc:creator>Susan E. Shoaf, Zhao Wang, Patricia Bricmont, Suresh Mallikaarjun</dc:creator>
<dc:date>2007-12-01</dc:date>
<dc:title><![CDATA[Pharmacokinetics, Pharmacodynamics, and Safety of Tolvaptan, a Nonpeptide AVP Antagonist, During Ascending Single-Dose Studies in Healthy Subjects]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/47/12/1540?rss=1&amp;ssource=mfc">
<title><![CDATA[Drug Interaction Studies of Therapeutic Proteins or Monoclonal Antibodies]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/47/12/1540?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Iftekhar Mahmood, Martin David Green<br />Dec  1, 2007; 47:1540-1554<br />Drug Interactions]]></description>
<dc:creator>Iftekhar Mahmood, Martin David Green</dc:creator>
<dc:date>2007-12-01</dc:date>
<dc:title><![CDATA[Drug Interaction Studies of Therapeutic Proteins or Monoclonal Antibodies]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/49/11/1297?rss=1&amp;ssource=mfc">
<title><![CDATA[Exposure-Response Analysis in Patients With Schizophrenia to Assess the Effect of Asenapine on QTc Prolongation]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/49/11/1297?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Sunny Chapel, Matt M. Hutmacher, George Haig, Howard Bockbrader, Rik de Greef, Sheldon H. Preskorn, Richard L. Lalonde<br />Nov  1, 2009; 49:1297-1308<br />Pharmacokinetics and Pharmacodynamics]]></description>
<dc:creator>Sunny Chapel, Matt M. Hutmacher, George Haig, Howard Bockbrader, Rik de Greef, Sheldon H. Preskorn, Richard L. Lalonde</dc:creator>
<dc:date>2009-11-01</dc:date>
<dc:identifier>10.1177/0091270009344855</dc:identifier>
<dc:title><![CDATA[Exposure-Response Analysis in Patients With Schizophrenia to Assess the Effect of Asenapine on QTc Prolongation]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/49/7/838?rss=1&amp;ssource=mfc">
<title><![CDATA[The Vytorin on Carotid Intima-Media Thickness and Overall Arterial Rigidity (VYCTOR) Study]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/49/7/838?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Alejandra Meaney, Guillermo Ceballos, Juan Asbun, Gustavo Solache, Emma Mendoza, Agustin Vela, Eduardo Meaney<br />Jul  1, 2009; 49:838-847<br />Pharmacodynamics]]></description>
<dc:creator>Alejandra Meaney, Guillermo Ceballos, Juan Asbun, Gustavo Solache, Emma Mendoza, Agustin Vela, Eduardo Meaney</dc:creator>
<dc:date>2009-07-01</dc:date>
<dc:title><![CDATA[The Vytorin on Carotid Intima-Media Thickness and Overall Arterial Rigidity (VYCTOR) Study]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/49/2/162?rss=1&amp;ssource=mfc">
<title><![CDATA[Population Pharmacokinetic Modeling of Ustekinumab, a Human Monoclonal Antibody Targeting IL-12/23p40, in Patients With Moderate to Severe Plaque Psoriasis]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/49/2/162?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Yaowei Zhu, Chuanpu Hu, Ming Lu, Sam Liao, Joseph C. Marini, Jennifer Yohrling, Newman Yeilding, Hugh M. Davis, Honghui Zhou<br />Feb  1, 2009; 49:162-175<br />Quantitative Clinical Pharmacology]]></description>
<dc:creator>Yaowei Zhu, Chuanpu Hu, Ming Lu, Sam Liao, Joseph C. Marini, Jennifer Yohrling, Newman Yeilding, Hugh M. Davis, Honghui Zhou</dc:creator>
<dc:date>2009-02-01</dc:date>
<dc:identifier>10.1177/0091270008329556</dc:identifier>
<dc:title><![CDATA[Population Pharmacokinetic Modeling of Ustekinumab, a Human Monoclonal Antibody Targeting IL-12/23p40, in Patients With Moderate to Severe Plaque Psoriasis]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/47/12/1532?rss=1&amp;ssource=mfc">
<title><![CDATA[Effect of High-Dose Metronidazole on Pharmacokinetics of Oral Budesonide and Vice Versa: A Double Drug Interaction Study]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/47/12/1532?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Karin Dilger, Richard Fux, Daniel Rock, Klaus Morike, Christoph H. Gleiter<br />Dec  1, 2007; 47:1532-1539<br />Drug Interactions]]></description>
<dc:creator>Karin Dilger, Richard Fux, Daniel Rock, Klaus Morike, Christoph H. Gleiter</dc:creator>
<dc:date>2007-12-01</dc:date>
<dc:identifier>10.1177/0091270007308617</dc:identifier>
<dc:title><![CDATA[Effect of High-Dose Metronidazole on Pharmacokinetics of Oral Budesonide and Vice Versa: A Double Drug Interaction Study]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/0091270009339191v1?rss=1&amp;ssource=mfc">
<title><![CDATA[Pharmacokinetics of Trans-resveratrol Following Repeated Administration in Healthy Elderly and Young Subjects]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/0091270009339191v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Teresa Nunes, MD, Luis Almeida, MD, PhD, FFPM, Jose-Francisco Rocha, BSc, Amilcar Falcao, PharmD, PhD, Carlos Fernandes-Lopes, BSc, Ana I. Loureiro, MSc, Lyndon Wright, PhD, M. Vaz-da-Silva, MD, PhD, Patricio Soares-da-Silva, MD, PhD<br />Oct  1, 2009; 0:9127000<br />]]></description>
<dc:creator>Teresa Nunes, MD, Luis Almeida, MD, PhD, FFPM, Jose-Francisco Rocha, BSc, Amilcar Falcao, PharmD, PhD, Carlos Fernandes-Lopes, BSc, Ana I. Loureiro, MSc, Lyndon Wright, PhD, M. Vaz-da-Silva, MD, PhD, Patricio Soares-da-Silva, MD, PhD</dc:creator>
<dc:date>2009-10-01</dc:date>
<dc:title><![CDATA[Pharmacokinetics of Trans-resveratrol Following Repeated Administration in Healthy Elderly and Young Subjects]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/49/7/824?rss=1&amp;ssource=mfc">
<title><![CDATA[The Absence of an Interaction Between Warfarin and Cranberry Juice: A Randomized, Double-Blind Trial]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/49/7/824?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Jack Ansell, Maryellen McDonough, Yanli Zhao, Jerold S. Harmatz, David J. Greenblatt<br />Jul  1, 2009; 49:824-830<br />Drug Interactions]]></description>
<dc:creator>Jack Ansell, Maryellen McDonough, Yanli Zhao, Jerold S. Harmatz, David J. Greenblatt</dc:creator>
<dc:date>2009-07-01</dc:date>
<dc:identifier>10.1177/0091270009337510</dc:identifier>
<dc:title><![CDATA[The Absence of an Interaction Between Warfarin and Cranberry Juice: A Randomized, Double-Blind Trial]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/44/1/7?rss=1&amp;ssource=mfc">
<title><![CDATA[Human Liver Aldehyde Oxidase: Inhibition by 239 Drugs]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/44/1/7?rss=1&amp;ssource=mfc</link>
<description><![CDATA[R. Scott Obach, Phuong Huynh, Mary C. Allen, Christine Beedham<br />Jan  1, 2004; 44:7-19<br />Drug Metabolism]]></description>
<dc:creator>R. Scott Obach, Phuong Huynh, Mary C. Allen, Christine Beedham</dc:creator>
<dc:date>2004-01-01</dc:date>
<dc:identifier>10.1177/0091270003260336</dc:identifier>
<dc:title><![CDATA[Human Liver Aldehyde Oxidase: Inhibition by 239 Drugs]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/47/3/383?rss=1&amp;ssource=mfc">
<title><![CDATA[Pharmacokinetics and Safety of Golimumab, a Fully Human Anti-TNF-{alpha} Monoclonal Antibody, in Subjects With Rheumatoid Arthritis]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/47/3/383?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Honghui Zhou, Haishan Jang, Roy M. Fleischmann, Esther Bouman-Thio, Zhenhua Xu, Joseph C. Marini, Charles Pendley, Qun Jiao, Gopi Shankar, Stanley J. Marciniak, Stanley B. Cohen, Mahboob U. Rahman, Daniel Baker, Mary Ann Mascelli, Hugh M. Davis, Daniel E. Everitt<br />Mar  1, 2007; 47:383-396<br />Biologics]]></description>
<dc:creator>Honghui Zhou, Haishan Jang, Roy M. Fleischmann, Esther Bouman-Thio, Zhenhua Xu, Joseph C. Marini, Charles Pendley, Qun Jiao, Gopi Shankar, Stanley J. Marciniak, Stanley B. Cohen, Mahboob U. Rahman, Daniel Baker, Mary Ann Mascelli, Hugh M. Davis, Daniel E. Everitt</dc:creator>
<dc:date>2007-03-01</dc:date>
<dc:identifier>10.1177/0091270006298188</dc:identifier>
<dc:title><![CDATA[Pharmacokinetics and Safety of Golimumab, a Fully Human Anti-TNF-{alpha} Monoclonal Antibody, in Subjects With Rheumatoid Arthritis]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/49/9/1056?rss=1&amp;ssource=mfc">
<title><![CDATA[Population Pharmacokinetics of Golimumab, an Anti-Tumor Necrosis Factor-{alpha} Human Monoclonal Antibody, in Patients With Psoriatic Arthritis]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/49/9/1056?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Zhenhua Xu, Thuy Vu, Howard Lee, Chuanpu Hu, Jie Ling, Hong Yan, Daniel Baker, Anna Beutler, Charles Pendley, Carrie Wagner, Hugh M. Davis, Honghui Zhou<br />Sep  1, 2009; 49:1056-1070<br />Special Populations]]></description>
<dc:creator>Zhenhua Xu, Thuy Vu, Howard Lee, Chuanpu Hu, Jie Ling, Hong Yan, Daniel Baker, Anna Beutler, Charles Pendley, Carrie Wagner, Hugh M. Davis, Honghui Zhou</dc:creator>
<dc:date>2009-09-01</dc:date>
<dc:title><![CDATA[Population Pharmacokinetics of Golimumab, an Anti-Tumor Necrosis Factor-{alpha} Human Monoclonal Antibody, in Patients With Psoriatic Arthritis]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/48/3/379?rss=1&amp;ssource=mfc">
<title><![CDATA[Metoclopramide, an Increasingly Recognized Cause of Tardive Dyskinesia]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/48/3/379?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Christopher Kenney, Christine Hunter, Anthony Davidson, Joseph Jankovic<br />Mar  1, 2008; 48:379-384<br />Brief Report/Pharmacoepidemiology]]></description>
<dc:creator>Christopher Kenney, Christine Hunter, Anthony Davidson, Joseph Jankovic</dc:creator>
<dc:date>2008-03-01</dc:date>
<dc:title><![CDATA[Metoclopramide, an Increasingly Recognized Cause of Tardive Dyskinesia]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/49/11/1309?rss=1&amp;ssource=mfc">
<title><![CDATA[Quantitative Population Pharmacokinetic Analysis of Pravastatin Using an Enterohepatic Circulation Model Combined With Pharmacogenomic Information on SLCO1B1 and ABCC2 Polymorphisms]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/49/11/1309?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Takafumi Ide, Tomohiro Sasaki, Kazuya Maeda, Shun Higuchi, Yuichi Sugiyama, Ichiro Ieiri<br />Nov  1, 2009; 49:1309-1317<br />Pharmacokinetics]]></description>
<dc:creator>Takafumi Ide, Tomohiro Sasaki, Kazuya Maeda, Shun Higuchi, Yuichi Sugiyama, Ichiro Ieiri</dc:creator>
<dc:date>2009-11-01</dc:date>
<dc:title><![CDATA[Quantitative Population Pharmacokinetic Analysis of Pravastatin Using an Enterohepatic Circulation Model Combined With Pharmacogenomic Information on SLCO1B1 and ABCC2 Polymorphisms]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/47/5/553?rss=1&amp;ssource=mfc">
<title><![CDATA[Molecular, Biologic, and Pharmacokinetic Properties of Monoclonal Antibodies: Impact of These Parameters on Early Clinical Development]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/47/5/553?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Mary Ann Mascelli, Honghui Zhou, Raymond Sweet, Jay Getsy, Hugh M. Davis, Martin Graham, Darrell Abernethy<br />May  1, 2007; 47:553-565<br />Biologics]]></description>
<dc:creator>Mary Ann Mascelli, Honghui Zhou, Raymond Sweet, Jay Getsy, Hugh M. Davis, Martin Graham, Darrell Abernethy</dc:creator>
<dc:date>2007-05-01</dc:date>
<dc:title><![CDATA[Molecular, Biologic, and Pharmacokinetic Properties of Monoclonal Antibodies: Impact of These Parameters on Early Clinical Development]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/0091270009347868v1?rss=1&amp;ssource=mfc">
<title><![CDATA[Pharmacokinetics and Safety of Sunitinib Malate in Subjects With Impaired Renal Function]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/0091270009347868v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Reza Khosravan, PhD, Melvin Toh, MD, May Garrett, BSc, JoAnn La Fargue, BA, Grace Ni, MS, Thomas C. Marbury, MD, Suzanne K. Swan, MD, Norman M. Lunde, MD, Carlo L. Bello, MS<br />Sep 24, 2009; 0:9127000<br />]]></description>
<dc:creator>Reza Khosravan, PhD, Melvin Toh, MD, May Garrett, BSc, JoAnn La Fargue, BA, Grace Ni, MS, Thomas C. Marbury, MD, Suzanne K. Swan, MD, Norman M. Lunde, MD, Carlo L. Bello, MS</dc:creator>
<dc:date>2009-09-24</dc:date>
<dc:title><![CDATA[Pharmacokinetics and Safety of Sunitinib Malate in Subjects With Impaired Renal Function]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/45/2/127?rss=1&amp;ssource=mfc">
<title><![CDATA[Interaction of Warfarin With Drugs, Natural Substances, and Foods]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/45/2/127?rss=1&amp;ssource=mfc</link>
<description><![CDATA[David J. Greenblatt, Lisa L. von Moltke<br />Feb  1, 2005; 45:127-132<br />Therapeutic Review]]></description>
<dc:creator>David J. Greenblatt, Lisa L. von Moltke</dc:creator>
<dc:date>2005-02-01</dc:date>
<dc:identifier>10.1177/0091270004271404</dc:identifier>
<dc:title><![CDATA[Interaction of Warfarin With Drugs, Natural Substances, and Foods]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/48/12/1389?rss=1&amp;ssource=mfc">
<title><![CDATA[Pharmacokinetics, Pharmacodynamics, Tolerability, and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Mellitus]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/48/12/1389?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Prajakti A. Kothare, Helle Linnebjerg, Yoshitaka Isaka, Kazunori Uenaka, Ayuko Yamamura, Kwee Poo Yeo, Amparo de la Pena, Choo Hua Teng, Kenneth Mace, Mark Fineman, Hirofumi Shigeta, Yukikuni Sakata, Shin Irie<br />Dec  1, 2008; 48:1389-1399<br />Pharmacokinetics and Pharmacodynamics]]></description>
<dc:creator>Prajakti A. Kothare, Helle Linnebjerg, Yoshitaka Isaka, Kazunori Uenaka, Ayuko Yamamura, Kwee Poo Yeo, Amparo de la Pena, Choo Hua Teng, Kenneth Mace, Mark Fineman, Hirofumi Shigeta, Yukikuni Sakata, Shin Irie</dc:creator>
<dc:date>2008-12-01</dc:date>
<dc:identifier>10.1177/0091270008323750</dc:identifier>
<dc:title><![CDATA[Pharmacokinetics, Pharmacodynamics, Tolerability, and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Mellitus]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/45/8/872?rss=1&amp;ssource=mfc">
<title><![CDATA[Multiple Drug Resistance in Cancer Revisited: The Cancer Stem Cell Hypothesis]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/45/8/872?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Vera S. Donnenberg, Albert D. Donnenberg<br />Aug  1, 2005; 45:872-877<br />Invited Review and Commentary]]></description>
<dc:creator>Vera S. Donnenberg, Albert D. Donnenberg</dc:creator>
<dc:date>2005-08-01</dc:date>
<dc:identifier>10.1177/0091270005276905</dc:identifier>
<dc:title><![CDATA[Multiple Drug Resistance in Cancer Revisited: The Cancer Stem Cell Hypothesis]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/49/7/758?rss=1&amp;ssource=mfc">
<title><![CDATA[Effect of Glucose-Insulin-Potassium Infusion on Mortality in Critical Care Settings: A Systematic Review and Meta-Analysis]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/49/7/758?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Michael A. Puskarich, Michael S. Runyon, Stephen Trzeciak, Jeffrey A. Kline, Alan E. Jones<br />Jul  1, 2009; 49:758-767<br />Review]]></description>
<dc:creator>Michael A. Puskarich, Michael S. Runyon, Stephen Trzeciak, Jeffrey A. Kline, Alan E. Jones</dc:creator>
<dc:date>2009-07-01</dc:date>
<dc:title><![CDATA[Effect of Glucose-Insulin-Potassium Infusion on Mortality in Critical Care Settings: A Systematic Review and Meta-Analysis]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/47/12/1508?rss=1&amp;ssource=mfc">
<title><![CDATA[Pharmacokinetics and Pharmacodynamics of Oral Heparin Solid Dosage Form in Healthy Human Subjects]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/47/12/1508?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Shaker A. Mousa, Fuming Zhang, Ahmad Aljada, Seema Chaturvedi, Majde Takieddin, Haifeng Zhang, Lianli Chi, M. Cristina Castelli, Kristen Friedman, Michael M. Goldberg, Robert J. Linhardt<br />Dec  1, 2007; 47:1508-1520<br />Pharmacokinetics and Pharmacodynamics]]></description>
<dc:creator>Shaker A. Mousa, Fuming Zhang, Ahmad Aljada, Seema Chaturvedi, Majde Takieddin, Haifeng Zhang, Lianli Chi, M. Cristina Castelli, Kristen Friedman, Michael M. Goldberg, Robert J. Linhardt</dc:creator>
<dc:date>2007-12-01</dc:date>
<dc:identifier>10.1177/0091270007307242</dc:identifier>
<dc:title><![CDATA[Pharmacokinetics and Pharmacodynamics of Oral Heparin Solid Dosage Form in Healthy Human Subjects]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/49/10/1228?rss=1&amp;ssource=mfc">
<title><![CDATA[Pharmacokinetics, Safety, and Tolerability of Phentermine in Healthy Participants Receiving Taranabant, a Novel Cannabinoid-1 Receptor (CB1R) Inverse Agonist]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/49/10/1228?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Carol Addy, Patricia Jumes, Kimberly Rosko, Susie Li, Hankun Li, Andrea Maes, Amy O. Johnson-Levonas, Jeffrey Chodakewitz, S. Aubrey Stoch, John A. Wagner<br />Oct  1, 2009; 49:1228-1238<br />Drug Interactions]]></description>
<dc:creator>Carol Addy, Patricia Jumes, Kimberly Rosko, Susie Li, Hankun Li, Andrea Maes, Amy O. Johnson-Levonas, Jeffrey Chodakewitz, S. Aubrey Stoch, John A. Wagner</dc:creator>
<dc:date>2009-10-01</dc:date>
<dc:identifier>10.1177/0091270009341651</dc:identifier>
<dc:title><![CDATA[Pharmacokinetics, Safety, and Tolerability of Phentermine in Healthy Participants Receiving Taranabant, a Novel Cannabinoid-1 Receptor (CB1R) Inverse Agonist]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/0091270009337134v1?rss=1&amp;ssource=mfc">
<title><![CDATA[Interspecies Scaling of Therapeutic Monoclonal Antibodies: Initial Look]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/0091270009337134v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Jie Ling, PhD, Honghui Zhou, PhD, FCP, Qun Jiao, MS, Hugh M. Davis, PhD<br />Oct 16, 2009; 0:9127000<br />]]></description>
<dc:creator>Jie Ling, PhD, Honghui Zhou, PhD, FCP, Qun Jiao, MS, Hugh M. Davis, PhD</dc:creator>
<dc:date>2009-10-16</dc:date>
<dc:title><![CDATA[Interspecies Scaling of Therapeutic Monoclonal Antibodies: Initial Look]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/43/5/443?rss=1&amp;ssource=mfc">
<title><![CDATA[The Conduct of In Vitro and In Vivo Drug-Drug Interaction Studies: A PhRMA Perspective]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/43/5/443?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Thorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf, Volker Fischer, Lawrence Gan, Scott Grimm, John Kao, S. Peter King, Gerald Miwa, Lan Ni, Gondi Kumar, James McLeod, Scott R. Obach, Stanley Roberts, Amy Roe, Anita Shah, Fred Snikeris, John T. Sullivan, Donald Tweedie, Jose M. Vega, John Walsh, Steven A. Wrighton<br />May  1, 2003; 43:443-469<br />Drug Development]]></description>
<dc:creator>Thorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf, Volker Fischer, Lawrence Gan, Scott Grimm, John Kao, S. Peter King, Gerald Miwa, Lan Ni, Gondi Kumar, James McLeod, Scott R. Obach, Stanley Roberts, Amy Roe, Anita Shah, Fred Snikeris, John T. Sullivan, Donald Tweedie, Jose M. Vega, John Walsh, Steven A. Wrighton</dc:creator>
<dc:date>2003-05-01</dc:date>
<dc:identifier>10.1177/0091270003252519</dc:identifier>
<dc:title><![CDATA[The Conduct of In Vitro and In Vivo Drug-Drug Interaction Studies: A PhRMA Perspective]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/49/8/937?rss=1&amp;ssource=mfc">
<title><![CDATA[A Thorough QTc Study to Assess the Effect of Sitagliptin, a DPP4 Inhibitor, on Ventricular Repolarization in Healthy Subjects]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/49/8/937?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Daniel M. Bloomfield, Rajesh Krishna, David Hreniuk, Lisa Hickey, Kalyan Ghosh, Arthur J. Bergman, Jutta Miller, Maria J. Gutierrez, Randall Stoltz, Keith M. Gottesdiener, Gary A. Herman, John A. Wagner<br />Aug  1, 2009; 49:937-946<br />Pharmacodynamics]]></description>
<dc:creator>Daniel M. Bloomfield, Rajesh Krishna, David Hreniuk, Lisa Hickey, Kalyan Ghosh, Arthur J. Bergman, Jutta Miller, Maria J. Gutierrez, Randall Stoltz, Keith M. Gottesdiener, Gary A. Herman, John A. Wagner</dc:creator>
<dc:date>2009-08-01</dc:date>
<dc:identifier>10.1177/0091270009337511</dc:identifier>
<dc:title><![CDATA[A Thorough QTc Study to Assess the Effect of Sitagliptin, a DPP4 Inhibitor, on Ventricular Repolarization in Healthy Subjects]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/49/10/1210?rss=1&amp;ssource=mfc">
<title><![CDATA[Coadministration of Pioglitazone or Glyburide and Alogliptin: Pharmacokinetic Drug Interaction Assessment in Healthy Participants]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/49/10/1210?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Aziz Karim, Aziz Laurent, Melvin Munsaka, Elisabeth Wann, Penny Fleck, Qais Mekki<br />Oct  1, 2009; 49:1210-1219<br />Drug Interactions]]></description>
<dc:creator>Aziz Karim, Aziz Laurent, Melvin Munsaka, Elisabeth Wann, Penny Fleck, Qais Mekki</dc:creator>
<dc:date>2009-10-01</dc:date>
<dc:title><![CDATA[Coadministration of Pioglitazone or Glyburide and Alogliptin: Pharmacokinetic Drug Interaction Assessment in Healthy Participants]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/43/3/211?rss=1&amp;ssource=mfc">
<title><![CDATA[Pharmacokinetic Strategies in Deciphering Atypical Drug Absorption Profiles]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/43/3/211?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Honghui Zhou<br />Mar  1, 2003; 43:211-227<br />Drug Development]]></description>
<dc:creator>Honghui Zhou</dc:creator>
<dc:date>2003-03-01</dc:date>
<dc:identifier>10.1177/0091270002250613</dc:identifier>
<dc:title><![CDATA[Pharmacokinetic Strategies in Deciphering Atypical Drug Absorption Profiles]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/46/1/10?rss=1&amp;ssource=mfc">
<title><![CDATA[An Overview of the Pharmacokinetics and Pharmacodynamics of Efalizumab: A Monoclonal Antibody Approved for Use in Psoriasis]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/46/1/10?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Amita Joshi, Robert Bauer, Peter Kuebler, Mark White, Cecelia Leddy, Peter Compton, Marvin Garovoy, Paul Kwon, Patricia Walicke, Russell Dedrick<br />Jan  1, 2006; 46:10-20<br />Therapeutic Review]]></description>
<dc:creator>Amita Joshi, Robert Bauer, Peter Kuebler, Mark White, Cecelia Leddy, Peter Compton, Marvin Garovoy, Paul Kwon, Patricia Walicke, Russell Dedrick</dc:creator>
<dc:date>2006-01-01</dc:date>
<dc:identifier>10.1177/0091270005283282</dc:identifier>
<dc:title><![CDATA[An Overview of the Pharmacokinetics and Pharmacodynamics of Efalizumab: A Monoclonal Antibody Approved for Use in Psoriasis]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/47/5/566?rss=1&amp;ssource=mfc">
<title><![CDATA[Nuclear Receptors and the Regulation of Drug-Metabolizing Enzymes and Drug Transporters: Implications for Interindividual Variability in Response to Drugs]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/47/5/566?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Bradley L. Urquhart, Rommel G. Tirona, Richard B. Kim<br />May  1, 2007; 47:566-578<br />]]></description>
<dc:creator>Bradley L. Urquhart, Rommel G. Tirona, Richard B. Kim</dc:creator>
<dc:date>2007-05-01</dc:date>
<dc:identifier>10.1177/0091270007299930</dc:identifier>
<dc:title><![CDATA[Nuclear Receptors and the Regulation of Drug-Metabolizing Enzymes and Drug Transporters: Implications for Interindividual Variability in Response to Drugs]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/49/8/984?rss=1&amp;ssource=mfc">
<title><![CDATA[Population Pharmacokinetic Analyses to Evaluate the Influence of Intrinsic and Extrinsic Factors on Exposure of Prasugrel Active Metabolite in TRITON-TIMI 38]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/49/8/984?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Rebecca E. Wrishko, C. Steven Ernest II, David S. Small, Ying G. Li, Govinda J. Weerakkody, Jeffrey R. Riesmeyer, William L. Macias, Shashank Rohatagi, Daniel E. Salazar, Elliott M. Antman, Stephen D. Wiviott, Eugene Braunwald, Lan Ni<br />Aug  1, 2009; 49:984-998<br />Pharmacokinetics]]></description>
<dc:creator>Rebecca E. Wrishko, C. Steven Ernest II, David S. Small, Ying G. Li, Govinda J. Weerakkody, Jeffrey R. Riesmeyer, William L. Macias, Shashank Rohatagi, Daniel E. Salazar, Elliott M. Antman, Stephen D. Wiviott, Eugene Braunwald, Lan Ni</dc:creator>
<dc:date>2009-08-01</dc:date>
<dc:title><![CDATA[Population Pharmacokinetic Analyses to Evaluate the Influence of Intrinsic and Extrinsic Factors on Exposure of Prasugrel Active Metabolite in TRITON-TIMI 38]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://www.jcp.sagepub.com/cgi/content/short/49/5/574?rss=1&amp;ssource=mfc">
<title><![CDATA[Clopidogrel Inhibits CYP2C19-Dependent Hydroxylation of Omeprazole Related to CYP2C19 Genetic Polymorphisms]]></title>
<link>http://www.jcp.sagepub.com/cgi/content/short/49/5/574?rss=1&amp;ssource=mfc</link>
<description><![CDATA[B. L. Chen, Y. Chen, J. H. Tu, Y. L. Li, W. Zhang, Q. Li, L. Fan, Z. R. Tan, D. L. Hu, D. Wang, L. S. Wang, D. S. OuYang, H. H. Zhou<br />May  1, 2009; 49:574-581<br />Drug Interactions]]></description>
<dc:creator>B. L. Chen, Y. Chen, J. H. Tu, Y. L. Li, W. Zhang, Q. Li, L. Fan, Z. R. Tan, D. L. Hu, D. Wang, L. S. Wang, D. S. OuYang, H. H. Zhou</dc:creator>
<dc:date>2009-05-01</dc:date>
<dc:identifier>10.1177/0091270009333016</dc:identifier>
<dc:title><![CDATA[Clopidogrel Inhibits CYP2C19-Dependent Hydroxylation of Omeprazole Related to CYP2C19 Genetic Polymorphisms]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

</rdf:RDF>